Characterizing the Role of Ophthalmologists in the Care of Patients With Suspected Giant Cell Arteritis at an Academic Medical Center

BACKGROUND: Evaluation and treatment of giant cell arteritis (GCA) is multidisciplinary, with high morbidity if not promptly treated. Ophthalmologists may be involved due to the presence of visual symptoms and/or ischemic vision loss. The goal of this study was to characterize the health care journey of patients suspected of having GCA and elucidate the role that ophthalmologists and other specialists play in their prebiopsy evaluation. METHODS: This retrospective study included patients at a single large academic institution who underwent a temporal artery biopsy (TAB) as part of a GCA evaluation over a 10-year period. Demographics, symptoms, laboratory testing, ancillary imaging, treatment initiation, biopsy results, and final diagnosis were extracted from the medical record. Types of specialists involved in different aspects of the prebiopsy evaluation for GCA were tabulated. A Sankey plot was created to visualize the included patients' journeys. RESULTS: Among 162 subjects undergoing TAB (average age of 74 years SD 11.3, 64.8% female, 60% ocular symptoms), 43 were diagnosed with GCA (30 positive TAB). Subjects saw an average of 3.31 providers (SD 1.15) from different specialties during their prebiopsy evaluation, with multiple patients seeing 6 different specialists. Within our cohort, 51% (n = 83) of patients saw ophthalmologists before TAB and 33% (n = 53) had their TAB performed by an ophthalmologist. Seeing an ophthalmologist during the prebiopsy period was not associated with a positive biopsy result (P = 0.80) or prebiopsy steroid treatment for GCA (P = 0.90). CONCLUSIONS: GCA suspects have a convoluted journey through our health care system and are commonly seen by multiple medical subspecialists during their evaluation. This may benefit patients due to multiple expert perspectives or may contribute to fragmentation of care and delays in treatment. These results reinforce the number of subspecialists, including ophthalmologists, who play a role in the evaluation of GCA. Multidisciplinary fast-track GCA clinics can both provide access to subspeciality care and simplify the patient journey.

Authors

Institutions

Publication Details

Journal
Journal of Neuro-Ophthalmology
Published
2026-06-16
DOI
https://doi.org/10.1097/wno.0000000000002485
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterizing the Role of Ophthalmologists in the Care of Patients With Suspected Giant Cell Arteritis at an Academic Medical Center

Katherine G. O'Neill, Heather E. Moss, Randall J. Brown
Journal of Neuro-Ophthalmology
Vasculitis and related conditions
article

Characterizing the Role of Ophthalmologists in the Care of Patients With Suspected Giant Cell Arteritis at an Academic Medical Center

Katherine G. O'Neill, Heather E. Moss, Randall J. Brown
article en

Abstract

BACKGROUND: Evaluation and treatment of giant cell arteritis (GCA) is multidisciplinary, with high morbidity if not promptly treated. Ophthalmologists may be involved due to the presence of visual symptoms and/or ischemic vision loss. The goal of this study was to characterize the health care journey of patients suspected of having GCA and elucidate the role that ophthalmologists and other specialists play in their prebiopsy evaluation. METHODS: This retrospective study included patients at a single large academic institution who underwent a temporal artery biopsy (TAB) as part of a GCA evaluation over a 10-year period. Demographics, symptoms, laboratory testing, ancillary imaging, treatment initiation, biopsy results, and final diagnosis were extracted from the medical record. Types of specialists involved in different aspects of the prebiopsy evaluation for GCA were tabulated. A Sankey plot was created to visualize the included patients' journeys. RESULTS: Among 162 subjects undergoing TAB (average age of 74 years SD 11.3, 64.8% female, 60% ocular symptoms), 43 were diagnosed with GCA (30 positive TAB). Subjects saw an average of 3.31 providers (SD 1.15) from different specialties during their prebiopsy evaluation, with multiple patients seeing 6 different specialists. Within our cohort, 51% (n = 83) of patients saw ophthalmologists before TAB and 33% (n = 53) had their TAB performed by an ophthalmologist. Seeing an ophthalmologist during the prebiopsy period was not associated with a positive biopsy result (P = 0.80) or prebiopsy steroid treatment for GCA (P = 0.90). CONCLUSIONS: GCA suspects have a convoluted journey through our health care system and are commonly seen by multiple medical subspecialists during their evaluation. This may benefit patients due to multiple expert perspectives or may contribute to fragmentation of care and delays in treatment. These results reinforce the number of subspecialists, including ophthalmologists, who play a role in the evaluation of GCA. Multidisciplinary fast-track GCA clinics can both provide access to subspeciality care and simplify the patient journey.

Journal of Neuro-Ophthalmology
Stanford Medicine (US), The University of Texas Medical Branch at Galveston (US), Stanford University (US)
Research to Prevent Blindness, National Institutes of Health
Good health and well-being
Openalex Percentile: Top 8%
Vasculitis and related conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.